Navigation Links
Research suggests popular diabetes drugs can cause abnormal pancreatic growth in humans
Date:3/27/2013

Individuals who had taken a type of drug commonly used to treat Type 2 diabetes showed abnormalities in the pancreas, including cell proliferation, that may be associated with an increased risk of neuroendocrine tumors, according to a new study by researchers from UCLA and the University of Florida. Their findings were published online March 22 in the journal Diabetes.

The researchers, from the Larry L. Hillblom Islet Research Center at UCLA and the Diabetes Center at the University of Florida, found that cell mass was increased approximately 40 percent in the pancreases of deceased organ donors who had Type 2 diabetes and who had been treated with incretin therapy. This widely used type of treatment takes advantage of the action of a gut hormone known as glucagon-like peptide 1 (GLP-1) to lower blood sugar in the body.

Although there have been conflicting reports on the effects of the incretin class of drugs on the pancreas in animal studies, this is the first study to note such changes in the human pancreas. The research was made possible by a unique research consortium called nPOD (Network for Pancreatic Organ Donors with Diabetes), led by Dr. Mark Atkinson, a professor of pathology and pediatrics at the University of Florida. The network, which is funded by the Juvenile Diabetes Research Foundation, obtains pancreases from deceased organ donors, with permission of their next of kin, to better understand diabetes by investigating tissues of those with the disease.

"There is an increasing appreciation that animal studies do not always predict findings in humans," said Dr. Peter Butler, director of UCLA's Hillblom Islet Research Center and chief of the endocrinology, diabetes and hypertension unit. "The nPOD program is therefore a very precious resource." The researchers examined the pancreases of 20 deceased organ donors with Type 2 diabetes. Eight had been treated for at least a year with incretin therapy, while th
'/>"/>

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles Health Sciences
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Frozen Food Production in the US Industry Market Research Report from IBISWorld has Been Updated
2. Moffitt researchers analyze HPV vaccination disparities among girls from low-income families
3. Penn research: Quitting marshmallow test can be a rational decision
4. Notre Dame researchers scoring a win-win with novel set of concussion diagnostic tools
5. GW professor researching ways to improve human tissue dissection, reduce blood transfusions
6. Researchers form new nerve cells &#8211 directly in the brain
7. Wake Forest Baptist research provides clues to alcohol addiction vulnerability
8. Research and Markets Announces the Release of Global Biobank (Biospecimen/Biorepository/Biopreservation) Market For Equipment & Media – Trends & Forecast to 2017
9. Moffitt Cancer Center researchers design small molecule to disrupt cancer-causing protein
10. UW researchers discover the brain origins of variation in pathological anxiety
11. Researchers decode biology of blood and iron disorders mapping out novel future therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 Back pain is a daily ... idea of instant powerful pain relief without taking a dangerous ... in technology have made this very possible. Enter on-line retailer ... iReliev Tens Unit electronic back massager. This ... back pain relief each and every day, in a ...
(Date:9/22/2014)... California (PRWEB) September 22, 2014 Plugin ... of ProSparkle. A fully customizable 3D particle emitter made ... “Adding the ProSparkle particle emitter plugin to a video ... Christina Austin, CEO of Pixel Film Studios. “ProSparkle gives ... described as cool” , With ProSparkle users are given ...
(Date:9/22/2014)... Cleveland, Ohio (PRWEB) September 22, 2014 ... to announce its recognition by ERC as ... award honors Northeast Ohio’s best places to work for ... their ability to build and maintain great workplaces that ... Areas which are evaluated include staffing and workforce, development ...
(Date:9/22/2014)... A Case Management Order (CMO) was issued on ... for testosterone lawsuit claims pending in multidistrict litigation in ... Wright & Schulte LLC notes the CMO, parties ... about potential witnesses and documents in testosterone therapy lawsuits. ... topics in Plaintiff Fact Sheets before another status conference ...
(Date:9/22/2014)... September 22, 2014 Reflecting their position ... iron products, Strictly Doors and Gates is now ... reasonable prices. The company offers quality wrought iron ornamental ... They have a versatile range of ornamental doors that ... will also get custom-made ornamental doors wherein their specifications ...
Breaking Medicine News(10 mins):Health News:Online Retailer Variety4Kicks Announces An Over The Counter Tens Unit For Back Pain Relief Is Now Available For Sale 2Health News:Announcing a new ProSparkle Particle Emitter Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:The Center for Health Affairs Named to 2014 NorthCoast 99 List 2Health News:The Center for Health Affairs Named to 2014 NorthCoast 99 List 3Health News:Judge Issues CMO For Testosterone Lawsuits Alleging Heart Attacks and Strokes Caused By "Low T" Drugs Such As Androgel 2Health News:Judge Issues CMO For Testosterone Lawsuits Alleging Heart Attacks and Strokes Caused By "Low T" Drugs Such As Androgel 3Health News:Judge Issues CMO For Testosterone Lawsuits Alleging Heart Attacks and Strokes Caused By "Low T" Drugs Such As Androgel 4Health News:Judge Issues CMO For Testosterone Lawsuits Alleging Heart Attacks and Strokes Caused By "Low T" Drugs Such As Androgel 5Health News:Strictly Doors and Gates Now Adding Ornamental Iron Gates to Their Products Line 2
... 6, GlaxoSmithKline (NYSE: GSK ) announced today ... Inc. (Sirtris),for approximately USD720 million (or approx. GBP362 ... USD22.50 (or approx. GBP11.33) per share., Through ... its,metabolic, neurology, immunology and inflammation research efforts by,establishing ...
... led by Professor Makoto Tominaga and Research Assistant Professor ... found that a sour taste receptor, PKD1L3-PKD2L1 channel complex, ... only after the removal of acid stimulus. They call ... taste receptor. They reports their finding in an international ...
... HOUSTON, June 6 Carriage Services, Inc.,(NYSE: ... its "Company & Investment,Profile", which can be found ... updated Company & Investment Profile includes updated,discussions of ... financial outlook and more., The Company & ...
... TreAura, Reminder Service, Edge Health Solutions brings Medicine 2.0 to ... ... RICHMOND, British Columbia, June 5 Edge Health,Solutions, innovators of medical ... Mac OS X, announces the,release of edgeMD 2.0(TM) and edgeDMS 2.0(TM). ...
... CHICAGO, June 5 In a June 5 joint ... America (ELCA) and,the Episcopal Church urged U.S. citizens to ... action" from the international community to restore,stability there., ... the Rev. Katharine Jefferts,Schori of the Episcopal Church made ...
... nearly halved in Dutch study , , THURSDAY, June 5 (HealthDay ... treatment of a heart attack reduced the one-year death rate ... cardiologists said could change medical practice. , The latest data ... that just 19 of 535 heart attack victims -- 3.6 ...
Cached Medicine News:Health News:Carriage Services Updates Company & Investment Profile 2Health News:Edge Health Solutions Releases edgeDMS(TM) 2.0 and edgeMD 2.0(TM), Revolutionary All-in-One Practice Management Software with FDA-Approved Advanced Visualization 2Health News:Lutheran, Episcopal Church Presiding Bishops Urge Prayers for Peace in Sudan 2Health News:Sucking Out Clot Debris Helps Heart Attack Patients 2Health News:Sucking Out Clot Debris Helps Heart Attack Patients 3
(Date:9/19/2014)... 2014 Today, iHealth Lab Inc. announced it has ... for its first institutional round of funding. The strategic ... reach, accelerate growth and innovation, and invest in additional ... Xiaomi Ventures will join iHealth,s board of directors, bringing ... ecommerce. "We are very pleased to have ...
(Date:9/19/2014)... DALLAS , September 19, 2014 ... Equipment Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), ... End Users (Hospitals), Advanced technologies - Global Forecast ... Market is poised to reach $19,786.3 Million by ... CAGR of 6.8% from 2014 to 2019. ...
(Date:9/19/2014)... WASHINGTON , Sept. 19, 2014 The ... that Drive Medical Design and Manufacturing has joined the ... its CEO Harvey Diamond have been actively ... year history, as it has quickly grown into a ... corporate partners like Drive allows AAHomecare to increase efforts ...
Breaking Medicine Technology:iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2
... Young Innovations, Inc. (Nasdaq: YDNT ) today announced that it will broadcast ... call on Wednesday, July 21, 2010 at 11:00 a.m. Central ... InterCall at http://tinyurl.com/yiq210 . Access to the live audio broadcast will also ... , , ...
... Ill. , July 14 RoundTable Healthcare ... the health-care industry, announced today that it has entered ... portfolio companies, Bioniche Pharma Holdings Limited ("Bioniche Pharma") to ... pharmaceutical company, for $550 million in cash. ...
Cached Medicine Technology:Young Innovations, Inc. Provides 2nd Quarter Conference Call Details 2RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc. 2RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc. 3
... enzyme immunoassay kit for the quantitative ... in serum. Enzyme immunoassay (EIA) permits ... protein hormones in body fluids and ... and specific assay. This enzyme immunoassay ...
SHIONORIA BNP,is a reagent used in the measurement of blood BNP. The blood BNP test allows accurate estimation of coronary functions....
... immunosorbent assay method for the semi-quantitative ... myeloperoxidase in human serum. The results ... used as an aid in the ... conditions associated with elevated anti-neutrophil cytoplasmic ...
... The determination of Ang II ... monitoring the pharmacological effect and ... of angiotensin converting enzyme inhibitors ... receptor antagonists as well as ...
Medicine Products: